Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01858545 · ClinicalTrials.gov registry record · NA
A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers
A NA study, sponsored by Integra LifeSciences Corporation.
- Terminated
- Registry status
- NA
- Development phase
- 56
- Enrollment target
NCT01858545: Clinical Trial NA study, sponsored by Integra LifeSciences Corporation.
NCT01858545 is a NA study that was terminated before completion, run by Integra LifeSciences Corporation. The registered enrollment target is 56 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01858545, a NA study, was terminated before completion, sponsored by Integra LifeSciences Corporation.
- TERMINATED
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
Study Summary
The primary objective of this study is to assess the effectiveness of MatriStem devices compared to cellular dermal replacement tissue, for the treatment of non-healing diabetic foot ulcers.
Primary Outcome
Number of participants with incidence of complete wound closure
Interventions
- DEVICE MatriStem
- DEVICE Cellular Dermal Replacement Tissue
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2013-05 |
| Est. Completion | 2015-12 |
| Phase | NA |
Why NCT01858545 stopped before completion
NCT01858545 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 2 interventions - of which MatriStem is the first listed.
NCT01858545 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01858545 about?
NCT01858545 is a clinical study titled "A Comparative Efficacy Study: Treatment for Non-healing Diabetic Foot Ulcers". The primary objective of this study is to assess the effectiveness of MatriStem devices compared to cellular dermal replacement tissue, for the treatment of non-healing diabetic foot ulcers.
What is the current status of trial NCT01858545?
This trial is currently terminated. It is a NA study. The enrollment target is 56 participants. The study started on 2013-05. Estimated completion is 2015-12.
What interventions are being tested in trial NCT01858545?
The interventions under investigation include: MatriStem (DEVICE), Cellular Dermal Replacement Tissue (DEVICE).
Who is sponsoring clinical trial NCT01858545?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01858545's enrollment target sits among peer trials
56 1262nd of 2000 higher than 737 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia